Indications |
Oral Mixed dyslipidaemia Adult: Initially, 10 or 20 mg daily, may increase at 4-wkly intervals. May initiate with 40 mg once daily in patients who require >45% reduction in low-density lipoprotein cholesterol. Max dose: 80 mg/day. Oral Nonfamilial hypercholesterolaemia Adult: Initially, 10 or 20 mg daily, may increase at 4-wkly intervals. May initiate with 40 mg once daily in patients who require >45% reduction in low-density lipoprotein cholesterol. Max dose: 80 mg/day. Oral Heterozygous familial hypercholesterolaemia Adult: Initially, 10 or 20 mg daily. Usual range depending on response: 10-80 mg daily. Child: 10-17 yr: Initially, 10 mg daily, adjust dose based on response. Max: 20 mg daily. |
Contraindications |
Hypersensitivity, active liver disease or unexplained persistent elevations of serum transaminase, porphyria, pregnancy, lactation. |
Warnings / Precautions |
Patients who consume substantial quantities of alcohol. History of liver disease. Patients with risk factors for myopathy or rhabdomyolysis. Hypothyroidism should be properly managed prior to starting statin therapy. Children <10 yr. Premenarcheal females. |
Adverse Reactions |
Headache, flatulence, diarrhoea, nausea, vomiting, anorexia, xerostomia, angioedema, myalgia, rash/pruritus, alopecia, allergy, infection, chest pain. Potentially Fatal: Thrombocytopenia. Rhabdomyolysis with acute renal failure. |
Overdose Reactions |
Symptomatic and supportive treatment. |
Drug Interactions |
Increased AUC for norethindrone and ethinyl estradiol. Concomitant multiple doses of atorvastatin and digoxin increased steady-state digoxin levels. Increased risk of rhabdomyolysis when used concurently with fibrates. Co-admin with antacid suspensions and colestipol decreased atorvastatin levels. See Below for More atorvastatin Drug Interactions |
Lab Interactions |
Biochemical abnormalities of liver function tests. |
Mechanism of Actions |
Atorvastatin competitively inhibits HMG-CoA reductase, the enzyme that catalyses the conversion of HMG-CoA to mevalonic acid. This results in the induction of the LDL receptors, leading to lowered LDL-cholesterol concentration. Absorption: Rapid from the GI tract (oral). Distribution: Protein-binding: 98%. Metabolism: Extensively hepatic; converted to active inhibitors of HMG-CoA reductase. Excretion: Faeces (as metabolites); 14 hr (elimination half-life). |
Administration |
May be taken with or without food. (Avoid excessive consumption (>1 L/day) of grapefruit juice.) |
ATC Classification |
C10AA05 - atorvastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia. |
Available As |
|
Atorvastatin
Post Review about Atorvastatin Click here to cancel reply.
Atorvastatin Containing Brands
Atorvastatin is used in following diseases
Drug - Drug Interactions of Atorvastatin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.